Added to YB: 2026-09-14
Pitch date: 2026-09-10
CRON [bullish]
Cronos Group Inc.
Author Info
H Capital is an M&A Consultant who writes about cheap, high potential stocks. Sign up for the newsletter.
Company Info
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
Market Cap
CAD 1.2B
Pitch Price
N/A
Price Target
10.00
Dividend
N/A
EV/EBITDA
32.52
P/E
17.05
EV/Sales
2.29
Sector
Pharmaceuticals
Category
growth
$CRON: I've been pounding the table on CRON for a while.
CRON: Cronos combines organic growth, margin expansion, acquisitions and buybacks, while cash and investments back roughly 71% of its market cap at a $3.16 share price. Q2 adjusted EBITDA margin reached 25%, and CanAdelaar is estimated at only 3.4x current EBITDA. A 2031 model supports $8.50 per share at 10x EV/EBITDA, or 170% upside, without U.S. legalization; execution depends partly on two additional acquisitions and sustained repurchases.
Read full article (3 min)